Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements (Q63258566)
Jump to navigation
Jump to search
scientific article published on 16 September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements |
scientific article published on 16 September 2011 |
Statements
Biomarkers in clinical trials for neurodegenerative diseases: regulatory perspectives and requirements (English)
Karl Broich
Marco Weiergräber
16 September 2011